Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02099734 · ClinicalTrials.gov registry record
Germ Cell Tumor and Testicular Tumor DNA Registry
A clinical trial of Germ Cell Tumor and Testicular Tumor, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 8
- Study locations
NCT02099734 is a study of Germ Cell Tumor and Testicular Tumor that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,000 participants, above the 295-participant average among 19 other Germ Cell Tumor trials with a reported enrollment target (239% higher). The trial reports 8 study locations across 2 states.
The verdict
NCT02099734, a study of Germ Cell Tumor and Testicular Tumor, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to patients with GCT and other testicular tumors will help us understand why some people get these tumors and why some people don't.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- OTHER sample of blood or saliva
Study Locations (8)
New York
- Cold Springs Harbor Laboratory (Specimen Analysis) - Cold Spring Harbor
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2014-01 |
| Est. Completion | 2028-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02099734
The ClinicalTrials.gov registry entry for NCT02099734 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 295-participant average among 19 other Germ Cell Tumor trials with a reported enrollment target (239% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Germ Cell Tumor appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT02099734 reports 8 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02099734 about?
NCT02099734 is a clinical study titled "Germ Cell Tumor and Testicular Tumor DNA Registry". This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diag...
What is the current status of trial NCT02099734?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2014-01. Estimated completion is 2028-01.
What conditions does trial NCT02099734 study?
This clinical trial studies the following conditions: Germ Cell Tumor, Testicular Tumor.
What interventions are being tested in trial NCT02099734?
The interventions under investigation include: Questionnaires (BEHAVIORAL), sample of blood or saliva (OTHER).
Who is sponsoring clinical trial NCT02099734?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02099734 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Germ Cell Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
RECRUITING · Phase 1
-
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RECRUITING · Phase 3
-
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
RECRUITING · Phase 3
-
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
RECRUITING · Phase 2
-
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.